SUBSCRIBERS
Endofotonics raises S$12m in Series B funding, led by Singapore Medical Group
Published Fri, May 29, 2020 · 09:50 PM
Singapore
CANCER diagnostic company Endofotonics on Friday said it has raised S$12 million in a Series B round led by executives from locally listed healthcare company Singapore Medical Group.
The additional funding will be used to drive commercialisation of its early gastric cancer detection system in the Asia-Pacific, and to expand the coverage of its cancer detection technology to other organs.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Former PAP MP, minister of state retire as company directors
US: Wall St opens higher
Air China orders homegrown C919s in challenge to jet duopoly
HCA beats first-quarter profit estimates on higher patient admissions
F&B operator YKGI to exclusively operate Chicha San Chen in Macau for next eight years
LMIRT Q1 net property income dips 3.1% to S$30 million on higher expenses